Spanish Infrastructure Stock News

BBVA stock closed at €24.2 after the market weighed in on its Q2 2026 numbers that delivered a punchy headline. The group posted net income of €3.062b for the quarter and €6.051b for the first half, with return on tangible equity around the low 20s that management calls best in class among big European banks. Short term traders are focused on the recent double digit share price gains. Long term investors are looking at a bank combining strong profitability with rising loans and a growing...

ACS Actividades de Construcción y Servicios stock has drifted lower in recent weeks, down about 11% over the past month, even as the price sits near €110 after the latest results. The short term mood looks cautious, but the earnings print tells a different story. Q2 revenue reached about €13.8b with basic earnings per share just over €1.05, and trailing 12 month earnings now sit above €1b. The key point for ACS is valuation. The stock trades on a P/E above the European construction average,...

Cirsa Enterprises stock has climbed steadily into this earnings season, with gains over the past week and month setting expectations high. The headline is not the share price. It is the profit rebuild. Net income from continuing operations over the last twelve months now sits above €160m, with net profit margin at 4.7% compared with just 0.6% a year earlier. The market is treating Cirsa as a financially stretched casino operator, focused on weak interest and dividend coverage, while the core...

Puig Brands walked into this earnings day with a stock that had slipped over the past three months yet traded on a P/E well below peers and below some fair value estimates. That set the stage for an emotion heavy session. The headline from the numbers is clear. Record first half net revenues of €2.35b and an adjusted EBITDA margin of 19.5% landed alongside an adjusted net profit of €260m. Investors now need to decide whether a lower valuation still reflects caution or if today’s beauty...

Pharma Mar stock closed at €80.15 after the market absorbed its half year 2026 update, leaving investors weighing a flat near term share price against a very different earnings picture. The company delivered resilient recurring oncology revenues and stayed cash generative, yet quarterly profit slipped into a small loss of €0.972m even as trailing twelve month earnings from continuing operations reached €56.126m. The real story now sits on the longer horizon. Royalty growth, the Zepzelca...

Redeia Corporación went into this print priced for steadiness, with the stock roughly flat over the past quarter. The latest move around €15.32 shows investors still testing that slow growth, high income story. The headline from Q2 is a squeeze on profitability. Quarterly net income of €123.7 million sits below Q1, even as revenue holds at €458.4 million, and trailing net profit margins are softer than last year. For a regulated grid operator that many holders treat as a bond substitute,...

Cox Infrastructure Group shares came into this earnings print on the back foot, with the stock down around 6% over the past month, yet the headline story is not the share price. The real shock is on the income line. Over the last twelve months the company swung from profit to a loss of €56.8 million, even as revenue reached €1.53b. That profit squeeze is what the market is trying to price in today, and it sets the emotional tone for how investors will read the rest of this report. Concerned...

Almirall (BME:ALM) is in focus after reporting half year 2026 results on 24 July, alongside a reiteration of full year guidance for net sales growth of 9% to 12%. See our latest analysis for Almirall. The reiteration of guidance comes after a mixed year for Almirall’s share price, with a 7-day share price return of 4.75% and a year-to-date share price return down 11.16%. The 3-year total shareholder return of 39.16% shows stronger longer term momentum. If today’s update has you thinking about...

Ercros stock closed at €3.485, with recent returns barely moving the needle over the past week and month. The share price looks calm on the surface. The earnings print is anything but. Q2 revenue landed at €214.397 million and flipped the company back into profit with net income of €9.705 million, after a run of quarterly losses. For a chemicals producer that has been unprofitable over the last twelve months and is expected to stay that way in forecasts, this single profitable quarter stands...

Why Vidrala’s latest earnings matter for shareholders Vidrala (BME:VID) has moved back into focus after its half year 2026 earnings on 23 July, with rising profit, firmer margins and a clear reaffirmation of full year financial targets. For the six months to 30 June 2026, Vidrala reported sales of €755.04 million compared with €751.14 million a year earlier. Net income was €117.4 million against €107.84 million, with basic earnings per share at €3.36 versus €3.0667. See our latest analysis...

The European stock market has shown resilience, with the pan-European STOXX Europe 600 Index rising by 0.46% amid robust corporate earnings and geopolitical tensions impacting oil prices. As investors navigate these complex conditions, identifying stocks that may be trading below their intrinsic value can present opportunities for those seeking potential growth in a volatile environment.

How Enagás earnings set the context for the stock Enagás (BME:ENG) has just reported half year 2026 results, with sales of €444.63 million and net income of €126.91 million, both lower than the same period a year earlier. Basic and diluted earnings per share from continuing operations were €0.49, compared with €0.68 a year ago. This gives investors fresh information to reassess how the stock’s current price reflects these figures. See our latest analysis for Enagás. Since the H1 2026 earnings...

Banco de Sabadell (BME:SAB) has reported Q2 2026 results with total revenue of €1,396 million and net income of €624 million, setting the tone for how the rest of the year may shape up for shareholders. The company has seen quarterly revenue move from €1,362 million in Q4 2025 to €1,046 million in Q1 2026 and then to €1,396 million in Q2 2026, while basic EPS tracked at €0.0776 in Q4 2025 and €0.0705 in Q1 2026. This gives investors a clearer view of how the top and bottom lines are pacing...

Grifols recently reported that the first patients have been dosed in two Phase 3 trials to expand U.S. labels for its flagship immunoglobulin therapies, GAMUNEX-C and XEMBIFY, targeting secondary immunodeficiency in certain blood cancers and chronic inflammatory demyelinating polyradiculoneuropathy. This push to broaden indications for existing plasma-derived products highlights how Grifols is trying to deepen its presence in complex, chronic immune-related conditions where immunoglobulin...

Investors in Laboratorios Farmaceuticos Rovi, S.A. ( BME:ROVI ) had a good week, as its shares rose 8.6% to close at...

Investors in Indra Sistemas, S.A. ( BME:IDR ) had a good week, as its shares rose 8.9% to close at €53.36 following the...

Vidrala, S.A. ( BME:VID ) shareholders are probably feeling a little disappointed, since its shares fell 5.3% to €86.00...

It's been a good week for Naturgy Energy Group, S.A. ( BME:NTGY ) shareholders, because the company has just released...

The new US tariff regime under Section 301 is quietly reshaping the playing field for global exporters, and European stocks are right in the middle of it. With lower duties for key countries like France, the UK, Germany, Spain, Belgium, and Italy, and higher rates for rivals such as Brazil, some European exporters now sit in a more favorable position in US trade. This article looks at how that shift connects to large European companies on our European Exporters screener and reveals 3 stocks...

CIE Automotive (BME:CIE) has drawn attention after reporting half year 2026 earnings, with sales, revenue, net income and earnings per share all higher than the figures reported a year earlier. See our latest analysis for CIE Automotive. Despite the stronger half year figures, CIE Automotive’s recent share price performance has been weak, with the stock at €25.8 and a year to date share price decline of 14.99%. However, the 5 year total shareholder return of 17.34% points to a more resilient...

Repsol’s share price has delivered very strong gains over the past five years, yet there is a clear split in what current valuation tools are signalling, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to sizeable upside while market based multiples suggest the stock is closer to expensive territory. The stock has returned 256.9% over five years, which raises the bar for any further upside to be supported by fundamentals. Recent profit strength and expansion in areas...

Indra Sistemas (BME:IDR) has put solid headline figures on the table for Q2 2026, with revenue of about €1.9b, basic EPS of €0.81 and net income of €143.1m, giving investors plenty to weigh as earnings season rolls on. The company has seen revenue move from €1.29b in Q2 2025 to €1.9b in Q2 2026, while quarterly basic EPS has shifted from €0.88 to €0.81 over the same period, framing a mixed picture on the top and bottom lines. With trailing net profit margin sitting below last year’s level,...

Laboratorios Farmaceuticos Rovi (BME:ROVI) has released its Q2 2026 results with revenue of €191.7 million and net income of €75.0 million, set against trailing 12 month revenue of €773.1 million, net income of €185.2 million, and Basic EPS of €3.61 that reflects a 40% year over year earnings increase. Over recent quarters the company has seen revenue move from €159.7 million in Q2 2025 to €210.5 million in Q3 2025, €218.4 million in Q4 2025, €152.5 million in Q1 2026 and now €191.7 million...

Banco Santander (BME:SAN) has posted its Q2 2026 numbers with revenue of about €12.1 billion and net income from continuing operations of €3.7 billion, setting the tone for a results season where profitability stays front and center. The bank has seen quarterly revenue move from €11.6 billion in Q1 2025 to €12.5 billion in Q4 2025 and €12.1 billion in Q1 2026, while basic EPS shifted from €0.19 in Q1 2025 to €0.20 in Q4 2025 and €0.23 in Q1 2026, giving investors a clear run-up of the top and...